>>Signaling Pathways>> Cell Cycle/Checkpoint>> G-quadruplex>>Pyridostatin (trifluoroacetate salt)

Pyridostatin (trifluoroacetate salt) (Synonyms: RR82 TFA)

Catalog No.GC48016

피리도스타틴(RR82) TFA는 G-quadruplex DNA 안정화제입니다(Kd=490nM). 피리도스타틴(트리플루오로아세테이트 염)은 복제 및 전사 의존성 DNA 손상을 유도하여 인간 암세포의 성장 정지를 촉진합니다. Pyridostatin(trifluoroacetate salt)은 proto-oncogene Src를 표적으로 합니다. 피리도스타틴(트리플루오로아세테이트 염)은 인간 유방암 세포에서 SRC 단백질 수준과 SRC 의존성 세포 운동성을 감소시켰습니다.

Products are for research use only. Not for human use. We do not sell to patients.

Pyridostatin (trifluoroacetate salt) Chemical Structure

Cas No.: 1472611-44-1

Size 가격 재고 수량
1 mg
US$42.00
재고 있음
5 mg
US$156.00
재고 있음
10 mg
US$292.00
재고 있음
25 mg
US$675.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Pyridostatin is a synthetic small-molecule stabilizer of G-quadruplexes, a secondary structure of DNA that usually exists in the end of the chromosome or the telomeres. It can compete for binding with the telomere-associated proteins and induce telomerase dysfunction. Pyridostatin induces DNA damage and cell cycle arrest (Kd = 490 nM) and has been shown to target the proto-oncogene Src, reducing Src protein abundance and Src-dependent motility in human breast cancer cells.1

1.Rodriguez, R., Miller, K.M., Forment, J.V., et al.Small-molecule-induced DNA damage identifies alternative DNA structures in human genesNat. Chem. Biol.8(3)301-310(2012)

리뷰

Review for Pyridostatin (trifluoroacetate salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 37 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Pyridostatin (trifluoroacetate salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.